ProfileGDS5068 / 204249_s_at
TitleRheumatoid arthritic synovium response to tocilizumab
OrganismHomo sapiens


baseline tocilizumab patient 1 patient 2 patient 3 patient 4 patient 5 patient 6 patient 7 patient 8 patient 9 patient 10 patient 11 patient 12 patient 1 patient 2 patient 3 patient 4 patient 5 patient 6 patient 7 patient 8 patient 9 patient 10 patient 11 patient 12 GSM1116933 GSM1116935 GSM1116937 GSM1116939 GSM1116941 GSM1116943 GSM1116945 GSM1116947 GSM1116949 GSM1116951 GSM1116953 GSM1116955 GSM1116934 GSM1116936 GSM1116938 GSM1116940 GSM1116942 GSM1116944 GSM1116946 GSM1116948 GSM1116950 GSM1116952 GSM1116954 GSM1116956 45% 48% 28% 88% 95% 16% 33% 78% 42% 92% 94% 20% 38% 11% 69% 88% 57% 89% 36% 13% 79% 80% 46% 46% sort by agent sort by individual Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1116933Synovial tissue prior to Tocilizumab therapy, repl 1-0.041695645
GSM1116935Synovial tissue prior to Tocilizumab therapy, repl 2-0.0030765548
GSM1116937Synovial tissue prior to Tocilizumab therapy, repl 3-0.10563828
GSM1116939Synovial tissue prior to Tocilizumab therapy, repl 40.25806288
GSM1116941Synovial tissue prior to Tocilizumab therapy, repl 50.36431495
GSM1116943Synovial tissue prior to Tocilizumab therapy, repl 6-0.21600316
GSM1116945Synovial tissue prior to Tocilizumab therapy, repl 7-0.12183433
GSM1116947Synovial tissue prior to Tocilizumab therapy, repl 80.13774378
GSM1116949Synovial tissue prior to Tocilizumab therapy, repl 9-0.036960642
GSM1116951Synovial tissue prior to Tocilizumab therapy, repl 100.3230192
GSM1116953Synovial tissue prior to Tocilizumab therapy, repl 110.39157694
GSM1116955Synovial tissue prior to Tocilizumab therapy, repl 12-0.14546920
GSM1116934Synovial tissue after to Tocilizumab therapy, repl 1-0.10077838
GSM1116936Synovial tissue after to Tocilizumab therapy, repl 2-0.31258111
GSM1116938Synovial tissue after to Tocilizumab therapy, repl 30.062017469
GSM1116940Synovial tissue after to Tocilizumab therapy, repl 40.41686388
GSM1116942Synovial tissue after to Tocilizumab therapy, repl 50.0030765557
GSM1116944Synovial tissue after to Tocilizumab therapy, repl 60.20481689
GSM1116946Synovial tissue after to Tocilizumab therapy, repl 7-0.088053736
GSM1116948Synovial tissue after to Tocilizumab therapy, repl 8-0.24480313
GSM1116950Synovial tissue after to Tocilizumab therapy, repl 90.1608379
GSM1116952Synovial tissue after to Tocilizumab therapy, repl 100.15688180
GSM1116954Synovial tissue after to Tocilizumab therapy, repl 11-0.0091180846
GSM1116956Synovial tissue after to Tocilizumab therapy, repl 12-0.011817946